Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Abroad (travel likely)RecruitingPHASE2

Conditions

Major Depressive Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham, Birmingham, Alabama, United States

  • University of Alabama at Birmingham-Huntsville, Huntsville, Alabama, United States

  • Wr-Pri, Llc, Encino, California, United States

  • Irvine Clinical Research, Irvine, California, United States

  • CalNeuro Research Group, Los Angeles, California, United States

  • Pacific Clinical Research Management Group LLC, Upland, California, United States

  • Sunwise Clinical Research LLC, Walnut Creek, California, United States

  • MCB Clinical Research Centers, Inc., Colorado Springs, Colorado, United States

  • Mountain View Clinical Research, Denver, Colorado, United States

  • University of Connecticut School of Medicine Psychiatry Department, Farmington, Connecticut, United States

  • Clinical Neuroscience Solutions, Inc., Jacksonville, Florida, United States

  • D&H Pompano Research Center, LLC, Margate, Florida, United States

  • Premier Clinical Research Institute, Inc., Miami, Florida, United States

  • Miami Dade Medical Research Institute, Miami, Florida, United States

  • Clinical Neuroscience Solutions, Inc., Orlando, Florida, United States

  • CenExel iRS (iResearch Savannah), Savannah, Georgia, United States

  • Revive Research Institute, Elgin, Illinois, United States

  • KUMC-Wichita, Wichita, Kansas, United States

  • Quantum Research Associates Corp., Louisville, Kentucky, United States

  • Boston Clinical Trials, Boston, Massachusetts, United States

  • Mayflower Clinical, Russells Mills, Massachusetts, United States

  • Vector Clinical Trials, Las Vegas, Nevada, United States

  • Neurobehavioral Research, Inc., Cedarhurst, New York, United States

  • Insight Clinical Trials LLC, Independence, Ohio, United States

  • Sooner Clinical Research, Inc., Oklahoma City, Oklahoma, United States

  • Lehigh Center for Clinical Research, Allentown, Pennsylvania, United States

  • Clinical Neuroscience Solutions, Inc., Memphis, Tennessee, United States

  • Austin Clinical Trial Partners, Austin, Texas, United States

  • InSite Clinical Research, LLC, DeSoto, Texas, United States

  • Baylor College of Medicine, Psychiatry and Behavioral Sciences, Houston, Texas, United States

  • Clinical Trials of Texas LLC, San Antonio, Texas, United States

  • Grayline Research Center, Wichita Falls, Texas, United States

  • Andes Clinical Research, Orem, Utah, United States

  • Northwest Clinical Research Center, Bellevue, Washington, United States

Study leads
  • Aaron Koenig, MD

    Study Chair

    Syndeio Biosciences